Successful treatment of subacute constrictive pericarditis with interleukin-1β receptor antagonist (anakinra)

Clinical and Experimental Rheumatology

Volumn 33, Issue 2, 2015, Pages 294-295

  D'Elia, Emilia ^a   Brucato, A ^a   Pedrotti, P ^b   Valenti, A ^a   de Amici, M ^c   Fiocca, L ^a   Duino, V ^a   Senni, M ^a   Imazio, M ^d   Martini, A ^e  

^a PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d MARIA VITTORIA HOSPITAL   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ANTIINFLAMMATORY AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; CONSTRICTIVE PERICARDITIS; DRUG COST; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HUMAN; LETTER; MIDDLE AGED; PLEURA EFFUSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY; DRUG COMBINATION; ECHOCARDIOGRAPHY; IMMUNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDITIS, CONSTRICTIVE; REMISSION; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MAGNETIC RESONANCE IMAGING, CINE; MIDDLE AGED; PERICARDITIS, CONSTRICTIVE; POSITRON-EMISSION TOMOGRAPHY; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84929939769     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. IMAZIO M, BRUCATO A, MAESTRONI S et al.: Risk of constrictive pericarditis after acute pericarditis. Circulation 2011; 124: 1270-5.
2. PICCO P, BRISCA G, TRAVERSO F et al.: Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?. Arthritis Rheum 2009; 60: 264-8.
3. BRUCATO A, IMAZIO M, SPODICK D, ADLER Y: Pathogenetic mechanism, new drugs, and old problems in idiopathic recurrent pericarditis: comment on the article by Picco et al. Arthritis Rheum 2009; 60: 2543.
4. FINETTI M, INSALACO A, CANTARINI L et al.: Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis. J Pediatr 2014; 164: 1425-31.
5. VASSILOPOULOS D, LAZAROS G, TSIOUFIS C, VASILEIOU P, STEFANADIS C, PECTASIDES D: Successful treatment of adult patients with idio-pathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra). Int J Cardiol 2012; 160: 66-8.
6. EMMI G, BARNINI T, SILVESTRI E et al.: A new case of idiopathic recurrent acute pericarditis due to R104Q mutation in TNFRSF1A successfully treated with anakinra: expanding the questions. Clin Exp Rheumatol 2014; 32: 297.
7. FENG DL, GLOCKNER J, KIM K et al.: Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antinflammatory medical therapy. A pilot study. Circulation 2011; 124: 1830-7.
8. MAESTRONI S, Di CORATO PR, CUMETTI D et al.: Recurrent pericarditis: autoimmune or autoinflammatory?. Autoimmun Rev 2012; 12: 60-5.